Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, September 2001, p. 899-903, Vol. 8, No. 5
Department of Infectious Diseases, University Medical
Centre1, and Institute of Microbiology
and Immunology, Medical Faculty,2 University
of Ljubljana, Ljubljana, Slovenia, and Viral and Rickettsial
Zoonoses Branch, Centers for Disease Control and Prevention,
Atlanta, Georgia3
Received 29 January 2001/Returned for modification 27 March
2001/Accepted 7 June 2001
An evaluation of the clinical outcome and the duration of the
antibody response of patients with human granulocytic ehrlichiosis (HGE) was undertaken in Slovenia. Adult patients with a febrile illness
occurring within 6 weeks of a tick bite were classified as having
probable or confirmed HGE based on the outcome of serological or PCR
testing. Thirty patients (median age, 44 years) were enrolled, and
clinical evaluations and serum collection were undertaken at initial
presentation and at 14 days, 6 to 8 weeks, and 3 to 4, 6, 12, 18, and
24 months. An indirect immunofluorescence assay (IFA) was performed,
and reciprocal titers of
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.5.899-903.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Clinical and Serological Follow-Up of Patients with
Human Granulocytic Ehrlichiosis in Slovenia
-Furlan,1,*
128 were interpreted as positive. Patients
presented a median of 4 days after the onset of fever and were febrile
for a median of 7.5 days; four (13.3%) received doxycycline.
Seroconversion was observed in 3 of 30 (10.0%) patients, and 25 (83.3%) showed >4-fold change in antibody titer. PCR results were
positive in 2 of 3 (66.7%) seronegative patients but in none of 27 seropositive patients at the first presentation. IFA antibody titers of
128 were found in 14 of 29 (48.3%), 17 of 30 (56.7%), 13 of 30 (43.4%), and 12 of 30 (40.0%) patients 6, 12, 18, and 24 months after
presentation, respectively. Patients reporting additional tick bites
during the study had significantly higher antibody titers at most time
points during follow-up. No long-term clinical consequences were found
during follow-up.
*
Corresponding author. Mailing address: Department of
Infectious Diseases, University Medical Centre, Japljeva 2, 1525 Ljubljana, Slovenia. Phone: (386 1) 2310 558. Fax: (386 1) 2302 781. E-mail: stanka.lotric-furlan{at}mf.uni-lj.si.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»